OBJECTIVES: To determine whether interleukin (IL)-6 or soluble tumor necrosis factor alpha receptor 1 (sTNF-αR1) is associated with depressive symptoms in the year after hip fracture. DESIGN: Prospective cohort. SETTING: Three Baltimore-area hospitals. PARTICIPANTS: Community-dwelling women aged 65 and older admitted with a new, nonpathological fracture of the proximal femur (N = 134). MEASUREMENTS: Two, 6, and 12 months after fracture, serum was analyzed for IL-6 and sTNF-αR1, and depressive symptoms were measured using the 15-item Geriatric Depression Scale (GDS). Generalized estimating equations were used to model the longitudinal relationship between IL-6, sTNF-αR1, and GDS score. Whether lower extremity function, as measured according to the Lower Extremity Gain Scale (LEGS), explained the relationship between IL-6, sTNF-αR1, and GDS score was also examined. RESULTS: Participants in the highest categories of IL-6 (≥5.14 pg/mL) and sTNF-αR1 (≥2,421 pg/mL) had the highest GDS scores in the year after fracture (P = .09 for both). Twelve months after fracture, those in the highest IL-6 and sTNF-αR1 categories had GDS scores that were on average 1.9 (95% confidence interval (CI) = 0.4-3.4, P = .01) and 1.4 (95% CI = -0.1-3.0, P = .07) points higher than those in the lowest category, respectively. Adjusting for LEGS score, the mean difference in GDS scores for highest versus lowest IL-6 categories was 1.6 (95% CI = 0.2-3.0, P = .02) points at 12 months. CONCLUSION: Results from these exploratory analyses support a role for inflammation in the pathophysiology of depressive symptoms after hip fracture. Depressive symptoms in the context of high cytokine levels may represent a sickness syndrome that is chronic in some individuals. Further research should establish the cause and effect of this relationship, as well as long-term correlates.
OBJECTIVES: To determine whether interleukin (IL)-6 or soluble tumor necrosis factor alpha receptor 1 (sTNF-αR1) is associated with depressive symptoms in the year after hip fracture. DESIGN: Prospective cohort. SETTING: Three Baltimore-area hospitals. PARTICIPANTS: Community-dwelling women aged 65 and older admitted with a new, nonpathological fracture of the proximal femur (N = 134). MEASUREMENTS: Two, 6, and 12 months after fracture, serum was analyzed for IL-6 and sTNF-αR1, and depressive symptoms were measured using the 15-item Geriatric Depression Scale (GDS). Generalized estimating equations were used to model the longitudinal relationship between IL-6, sTNF-αR1, and GDS score. Whether lower extremity function, as measured according to the Lower Extremity Gain Scale (LEGS), explained the relationship between IL-6, sTNF-αR1, and GDS score was also examined. RESULTS:Participants in the highest categories of IL-6 (≥5.14 pg/mL) and sTNF-αR1 (≥2,421 pg/mL) had the highest GDS scores in the year after fracture (P = .09 for both). Twelve months after fracture, those in the highest IL-6 and sTNF-αR1 categories had GDS scores that were on average 1.9 (95% confidence interval (CI) = 0.4-3.4, P = .01) and 1.4 (95% CI = -0.1-3.0, P = .07) points higher than those in the lowest category, respectively. Adjusting for LEGS score, the mean difference in GDS scores for highest versus lowest IL-6 categories was 1.6 (95% CI = 0.2-3.0, P = .02) points at 12 months. CONCLUSION: Results from these exploratory analyses support a role for inflammation in the pathophysiology of depressive symptoms after hip fracture. Depressive symptoms in the context of high cytokine levels may represent a sickness syndrome that is chronic in some individuals. Further research should establish the cause and effect of this relationship, as well as long-term correlates.
Authors: E J Lenze; J C Rogers; L M Martire; B H Mulsant; B L Rollman; M A Dew; R Schulz; C F Reynolds Journal: Am J Geriatr Psychiatry Date: 2001 Impact factor: 4.105
Authors: Sheryl Zimmerman; William G Hawkes; J Richard Hebel; Kathleen M Fox; Eva Lydick; Jay Magaziner Journal: Arch Phys Med Rehabil Date: 2006-03 Impact factor: 3.966
Authors: Denise L Orwig; Marc Hochberg; Janet Yu-Yahiro; Barbara Resnick; William G Hawkes; Michelle Shardell; J Richard Hebel; Perry Colvin; Ram R Miller; Justine Golden; Sheryl Zimmerman; Jay Magaziner Journal: Arch Intern Med Date: 2011-02-28
Authors: Alan M Rathbun; Michelle D Shardell; Elizabeth A Stuart; Ann L Gruber-Baldini; Denise Orwig; Glenn V Ostir; Gregory E Hicks; Marc C Hochberg; Jay Magaziner Journal: Int J Geriatr Psychiatry Date: 2018-02-26 Impact factor: 3.485
Authors: Niharika Arora Duggal; Jane Upton; Anna C Phillips; Peter Hampson; Janet M Lord Journal: Brain Behav Immun Date: 2013-07-20 Impact factor: 7.217